Developing viruses to treat infections caused by mycobacteria.
SBIR Topic 131: Development of Bacteriophage for Treatment of Mycobacterial Infections
['FUNDING_OTHER'] · VULCAN BIOLOGICS, INC. · NIH-11203278
This study is exploring new treatments using special viruses that can target and kill tough bacteria, especially for people dealing with hard-to-treat infections that antibiotics struggle with, so patients can have better options for their health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VULCAN BIOLOGICS, INC. (nih funded) |
| Locations | 1 site (IRVINE, UNITED STATES) |
| Trial ID | NIH-11203278 on ClinicalTrials.gov |
What this research studies
This research focuses on creating therapeutic products using bacteriophages, which are viruses that specifically target and kill mycobacteria, including those that are resistant to antibiotics. The project emphasizes preclinical development, particularly for non-tuberculous mycobacterial (NTM) infections, which can be challenging to treat with standard antibiotics. Patients may benefit from innovative treatments that could effectively combat these difficult infections. The approach involves rigorous testing and development to ensure safety and efficacy before moving to clinical trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with mycobacterial infections, particularly those resistant to conventional antibiotic treatments.
Not a fit: Patients with infections caused by bacteria other than mycobacteria may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option for patients suffering from antibiotic-resistant mycobacterial infections.
How similar studies have performed: Previous research has shown promise in using bacteriophages to treat bacterial infections, indicating potential success for this novel approach.
Where this research is happening
IRVINE, UNITED STATES
- VULCAN BIOLOGICS, INC. — IRVINE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GREEN, BRIAN — VULCAN BIOLOGICS, INC.
- Study coordinator: GREEN, BRIAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.